SACK1H and hepatocellular carcinoma: Therefore, our result suggests that therapeutic stratagems targeting the MYC-FAM83H signaling pathway, especially for the FAM83H-expressing poor prognostic subgroup of HCC, might be effective for the treatment of HCC patients.